Last reviewed · How we verify

NCT05420441

Chitosan Versus Glucosamine Phonophoresis in the Management of Knee Osteoarthritis

Status unknown NA Last updated 15 June 2022
What this trial tests

NA trial testing Phonophoresis with chitosan in Knee Osteoarthritis in 60 participants. Status unknown.

Timeline
25 April 2022
Primary endpoint
30 September 2022
1 October 2022

Quick facts

Lead sponsorOctober 6 University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment60
Start date25 April 2022
Primary completion30 September 2022
Estimated completion1 October 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

October 6 University

Who can join

Adults 45 to 60, any sex, with Knee Osteoarthritis or Knee Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will be conducted to answer the following questions: * Is there an effect of phonophoresis using glucosamine on pain level , function and range of motion in knee osteoarthritis patients ? * Is there an effect of phonophoresis using chitosan on pain level , function and range of motion in knee osteoarthritis patients ? * Is there a difference between the effect of phonophoresis using glucosamine and phonophoresis using chitosan on pain level , function and range of motion in knee osteoarthritis patients ?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other October 6 University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05420441.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing